                 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
                            WASHINGTON, D.C.  20460

                                         OFFICE OF CHEMICAL SAFETY
                                                      AND POLLUTION PREVENTION

MEMORANDUM

Date:  		9/7/2012

SUBJECT:	Fluazinam  Acute and Chronic Aggregate Dietary (Food and Drinking Water) Exposure and Risk Assessments for the Section 3 Registration Action on Soybeans, the Melon Subgroup (9A), and the Pepper/Eggplant Subgroup (8-10B)

PC Code:  129098
DP Barcode:  D397722
Decision Nos.:  459107
Registration No.: 71512-1
Petition:  1E7959, 2F7977
Regulatory Action:  Section 3 Registration
Risk Assessment Type:  Dietary
Case No.:  7013
TXR No.:  NA
CAS No.:  79622-59-6
MRID No.:  NA
40 CFR:  §180.574

FROM:  	Douglas Dotson, Ph.D., Chemist
		Risk Assessment Branch II
		Health Effects Division (7509P)

THROUGH:	Nancy Dodd, Chemist
		Ideliz Negrón-Encarnación, Ph.D., Chemist
		Dietary Exposure Science Advisory Council

      and

      Christina Swartz, Branch Chief
		Risk Assessment Branch II
		Health Effects Division (7509P)

TO:		Andrew Ertman/Barbara Madden, RM Team 5, RIMUERB
		Dominic Schuler/Tony Kish, PM Team 22, Fungicide Branch
		Registration Division (7505P)

Executive Summary

Acute and chronic aggregate dietary (food and drinking water) exposure and risk assessments were conducted using the Dietary Exposure Evaluation Model DEEM-FCID, Version 3.16 which uses food consumption data from the U.S. Department of Agriculture's National Health and Nutrition Examination Survey, What We Eat in America, (NHANES/WWEIA).  This dietary survey was conducted from 2003 to 2008.  The analyses were conducted as part of a human health risk assessment for the proposed use of fluazinam on soybeans, the melon subgroup (9B) and the pepper/eggplant subgroup (8-10B).  The estimated drinking water concentrations (EDWCs) are based on a currently registered use on turf.

The acute analysis is based on tolerance-level residues for all commodities and uses high-end residue estimates for the metabolite AMGT.  In addition, the acute assessment assumes 100% crop treated and incorporates modeled estimated drinking water concentrations (EDWCs) that account for both parent fluazinam and its transformation products.  Therefore, the resulting exposure and risk estimates are considered to be very conservative.  The acute risk estimates at the 95[th] percentile of exposure are below HED's level of concern for all population subgroups, including those comprised of infants and children.  Generally, HED is concerned when risk estimates exceed 100% of the population-adjusted dose (PAD).  The acute risk estimate for the general U.S. population is 5.3% of the acute PAD (aPAD).  The population subgroup with the highest acute dietary risk estimate is Females 13-49, which uses 28% of the aPAD.

The chronic analysis is based on tolerance-level residues for all commodities except apples.  For apples, the average field trial value was used.  As with the acute assessment, it assumes high-end estimates for AMGT, 100% crop treated, and incorporates modeled EDWCs that account for both parent and transformation products.  The resulting exposure and risk estimates are considered to be conservative.  Chronic risk estimates are below HED's level of concern for all population subgroups.  The risk estimate for the general U.S. population is 20% of the chronic PAD (cPAD).  The most highly exposed population subgroup is Children 1-2, which uses 51% of the cPAD.

Fluazinam is classified as having "suggestive evidence of carcinogenicity, but not sufficient to assess human carcinogenic potential."  The CARC determined that quantification of risk using a non-linear approach (i.e., RfD) will adequately account for all chronic toxicity, including carcinogenicity, that could result from exposure to fluazinam.  As a result, the chronic dietary exposure assessment is protective for potential cancer risk.

I.   Introduction

Dietary risk assessment incorporates both exposure and toxicity of a given pesticide.  For acute and chronic assessments, the risk is expressed as a percentage of a maximum acceptable dose (i.e., the dose which HED has concluded will result in no unreasonable adverse health effects).  This dose is referred to as the population-adjusted dose (PAD).  The PAD is equivalent to the point of departure (e.g., POD, NOAEL, or LOAEL) divided by the required uncertainty or safety factors.
For acute and non-cancer chronic exposures, HED is concerned when estimated dietary risk exceeds 100% of the PAD.  References which discuss the acute and chronic risk assessments in more detail are available on the EPA/pesticides web site:  "Available Information on Assessing Exposure from Pesticides, A User's Guide," 21 Jun 2000, web link:  http://www.epa.gov/ fedrgstr/EPA-PEST/2000/July/Day-12/6061.pdf; or see SOP 99.6 (20 Aug 1999).  The most recent dietary risk assessment for fluazinam was conducted by D. Dotson (D394960, 2/7/2012).

II.   Residue Information

Fluazinam is currently registered in the U.S. for use on carrots, potatoes, ginseng, the Bulb onion subgroup (3-07A), head lettuce, leaf lettuce, Crop Group 5 (Brassica leafy vegetables), turnip greens, peanuts, apples, the Bushberry subgroup (13-07B), and Crop subgroups 6-A (except pea), 6-B (except pea), and 6-C (except pea).  In addition, there is a tolerance without U.S. registration on wine grapes.  Tolerances for these commodities range from 0.01 ppm for the Brassica leafy vegetables and turnip greens to 7.0 ppm for the Bushberry subgroup.  Tolerances have also been established for residues in the fat and meat byproducts of cattle, goats, horses, and sheep.  The tolerances for fluazinam are listed in 40 CFR 180.574.

The metabolite AMGT is a residue of concern for some commodities, but not for others.  The residue of concern for risk assessment in peanuts, bulb vegetables, and root and tuber vegetables is parent fluazinam.  For all other plant commodities, the residues of concern in plants for risk assessment are fluazinam and its metabolite AMGT.  In the crop field trials that were performed, AMGT was measured in some commodities but not in others.  As a result, the residue levels that were used in the dietary exposure assessments were determined in different ways.

As the residue of concern in peanuts, bulb vegetables, and root and tuber vegetables is parent only, tolerance-level residues were used for these commodities.

For the commodities in the current tolerance petitions (soybeans, cantaloupe, and peppers), residues of parent fluazinam as well as residues of AMGT were measured in the field trial studies.  For these commodities, the LOQ for AMGT was 0.01 ppm.  All samples had residue levels below the LOQ.  As a result, the total residue used in the dietary exposure assessment was the tolerance plus 0.01 ppm.  Both fluazinam and AMGT were also measured in the grape and apple field trials.  The 3.0 ppm tolerance for grapes covers all residues of concern.  The fluazinam apple tolerance is 2.0 ppm, and the highest combined (fluazinam + AMGT) residue is below the tolerance (1.69 ppm).  The tolerance was used in the acute assessment and the average combined (fluazinam + AMGT) residue value of 0.215 ppm was used in the chronic assessment.

For bushberries, the mean ratio of the metabolite:parent residues (0.11:1) from field trials was used to estimate the total residues of concern, and the bushberry tolerance of 7.0 ppm was multiplied by a factor of 1.11.

For the other commodities, an upper-bound ratio of 0.35:1 (AMGT:fluazinam) was used to estimate the AMGT residue.  This factor is the maximum AMGT:fluazinam ratio in grapes determined in the grape metabolism study.  The values obtained using this ratio were used in both the acute and chronic assessments.  For more information concerning the residue levels used in the dietary exposure assessments, see the last dietary exposure memos that were written for fluazinam (D276982, W. Cutchin, 8/22/2001; D340854, M. Doherty, 8/1/2007; and D374522, D. Dotson, 3/31/2010).

In livestock commodities, the residues of concern for risk assessment and tolerance enforcement are the same:  parent fluazinam, its metabolites AMPA and DAPA, and their sulfamate conjugates.  The tolerance level of 0.05 ppm is being used for meat byproducts and fat of cattle, goats, horses, and sheep (Memo, D360840, D. Dotson, 3/31/2010).  This value is very conservative because it accounts for all residues of concern in the livestock commodities for which tolerances have been established.

DEEM 7.81 default processing factors were used for all processed commodities for which they were available.  Full listings of the residue inputs used in the analyses are included as Attachments 1 and 3.

Table 1.  Summary of Crop Residue Levels Used in the Acute and Chronic
       Dietary Exposure Analyses
Crop/Crop Group
                                Tolerance Level
                                     (ppm)
                    Residue Level used in Assessments (ppm)
                                 Derivation of
                                 Residue Level
Carrots
0.70
0.70
                            Tolerance (parent only)
Potatoes
0.02
0.02
                            Tolerance (parent only)
Ginseng
4.5
4.5
                            Tolerance (parent only)
Bulb Onions (Subgroup 3-07A)
0.20
0.20
                            Tolerance (parent only)
Head Lettuce
0.02
0.027
0.02 tolerance x 1.35
Leaf Lettuce
2.0
2.7
2.0 tolerance x 1.35
Brassica Leafy Vegetables
0.01
0.0135
0.01 tolerance x 1.35
Turnip Greens
0.01
0.0135
0.01 tolerance x 1.35
Edible-Podded Legumes, Subgroup 6-A, except pea
0.10
0.135
0.1 tolerance x 1.35
Succulent Shelled Legumes, Subgroup 6-B, except pea
0.04
0.054
                             0.04 tolerance x 1.35
Dried Shelled Legumes, Subgroup 6-C, except pea
0.02
0.027
                             0.02 tolerance x 1.35
Soybean
0.01
0.02
                               Tolerance + 0.01
Peanuts
0.02
0.02
                            Tolerance (parent only)
Peppers/Eggplant (8-10B)
0.09
0.10
                               Tolerance + 0.01
Melons (9A)
0.07
0.08
                               Tolerance + 0.01
Apples (Acute Assessment)
2.0
2.0
                      Tolerance includes parent and AMGT
Apples (Chronic Assessment)
2.0
0.215
                    Avg combined residue (fluazinam + AMGT)
Bushberry Subgroup 13-07B
7.0
7.8
                               Tolerance x 1.11
Wine Grapes (imported)
3.0
3.0
                      Tolerance includes parent and AMGT
Fat of cattle, goat, horse, and sheep
0.05
0.05
                                   Tolerance
Meat byproducts of cattle, goat, horse, and sheep
0.05
0.05
                                   Tolerance

Residues in Fish

Tolerances have not been established for fish commodities.  Fluazinam has a low water solubility and a relatively high octanol/water partition coefficient.  As a result, it will not dissolve in water to any significant extent.  Residues have the potential to partition into sediment at the bottoms of water bodies, however.  Catfish are bottom feeders and residues in catfish serve as a marker for pesticide residues.  The USDA Pesticide Data Program (PDP) monitored pesticide residues in catfish in 2008, 2009, and 2010.  The catfish samples were not analyzed for fluazinam, however.  As a result, residues in fish were not included in the dietary exposure assessments.

III.   Percent Crop Treated Information

The acute and chronic assessments were both based on the assumption that 100% of all commodities with fluazinam tolerances will be treated.

IV.   Drinking Water Data

The drinking water residues used in the dietary risk assessment were provided by the Environmental Fate and Effects Division (EFED; D391184, J. Meléndez, 8/3/2011) and incorporated directly into this dietary assessment into the food categories "water, direct, all sources" and "water, indirect, all sources."  The residues of concern in drinking water for risk assessment are parent fluazinam and its transformation products, including DCPA, CAPA, DAPA, HYPA, and AMPA.

The estimated acute and chronic EDWCs are based on ground application of fluazinam to turf.  The values are provided in Table 2, below.  The groundwater value was generated using the Screening Concentration in Groundwater (SCI-GROW) Model and the surface water values were generated using the FQPA Index Reservoir Screening Tool (FIRST) Model.  The surface water estimates were used for both the acute and chronic assessments because they were higher than the groundwater value.  Both acute and chronic estimates included parent and degradates.  For the acute assessment, a value of 226 ppb was used, and for the chronic assessment, a value of 37.8 ppb was used.  This value also includes both parent and degradates.  For more information about EFED's drinking water models, see http://www.epa.gov/oppefed1/models/ water.

Table 2.  Maximum Tier 1 Estimated Drinking Water Concentrations Based on Ground
        Application of Fluazinam to Turf at a Seasonal Rate of 8.4 lb a.i./A
                                 Source/Model
                                   Fluazinam
                        Total Residues of Fluazinam[1]

                                   Acute/ppb
                                  Chronic/ppb
                                   Acute/ppb
                                  Chronic/ppb
                              Surface Water/FIRST
                                     217 2
                                     1.47
                                     226 2
                                     37.8
                             Groundwater/SCI-GROW
                                     0.404
1. Including the following transformation products: DCPA, HYPA, CAPA, DAPA, and AMPA.
[2][.] Exceeds the solubility of fluazinam at pH 7 (71 ppb), but not the solubility at pH 11 (350 ppm).

V.   DEEM-FCID Program and Consumption Information

Fluazinam acute and chronic dietary exposure assessments were conducted using the Dietary Exposure Evaluation Model software with the Food Commodity Intake Database DEEM-FCID, Version 3.16, which incorporates consumption data from USDA's NHANES/WWEIA.  This dietary survey was conducted from 2003 to 2008.  The data are based on the reported consumption of more than 20,000 individuals over two non-consecutive survey days.  Foods "as consumed" (e.g., apple pie) are linked to EPA-defined food commodities (e.g. apples, peeled fruit - cooked; fresh or N/S; baked; or wheat flour - cooked; fresh or N/S, baked) using publicly available recipe translation files developed jointly by USDA/ARS and EPA.  For chronic exposure assessment, consumption data are averaged for the entire U.S. population and within population subgroups.  However, for acute exposure assessment, consumption data are retained as individual consumption events.  Based on analysis of the 2003-2008 WWEIA consumption data, which took into account dietary patterns and survey respondents, HED concluded that it is most appropriate to report risk for the following population subgroups: the general U.S. population, all infants (<1 year old), children 1-2, children 3-5, children 6-12, youth 13-19, adults 20-49, females 13-49, and adults 50-99 years old.

For chronic dietary exposure assessment, an estimate of the residue level in each food or food-form (e.g., orange or orange juice) on the food commodity residue list is multiplied by the average daily consumption estimate for that food/food form to produce a residue intake estimate.  The resulting residue intake estimate for each food/food form is summed with the residue intake estimates for all other food/food forms on the commodity residue list to arrive at the total average estimated exposure.  Exposure is expressed in mg/kg body weight/day and as a percent of the cPAD.  This procedure is performed for each population subgroup.

For acute exposure assessments, individual one-day food consumption data are used on an individual-by-individual basis.  The reported consumption amounts of each food item can be multiplied by a residue point estimate and summed to obtain a total daily pesticide exposure for a deterministic exposure assessment, or "matched" in multiple random pairings with residue values and then summed in a probabilistic assessment.  The resulting distribution of exposures is expressed as a percentage of the aPAD on both a user (i.e., only those who reported eating relevant commodities/food forms) and a per-capita (i.e., those who reported eating the relevant commodities as well as those who did not) basis.  In accordance with HED policy, per capita exposure and risk are reported for assessments performed at all levels of refinement.  However, for unrefined assessments, any significant differences in user vs. per capita exposure and risk are specifically identified and noted in the risk assessment.

VI.   Toxicological Information

The toxicity data show that the primary target organ for chronic exposure to fluazinam is the liver.  Liver effects in mice served as the basis for the chronic dietary endpoint.  Acute neurotoxicity was seen in rats, and developmental toxicity was seen in rabbits.  For acute dietary exposure assessment, different endpoints were selected for the general U.S. population and Females 13-49.  The FQPA Safety Factor was reduced to 1x for all population subgroups.  The CARC determined that quantification of risk using a non-linear approach (i.e., RfD) will adequately account for all chronic toxicity, including carcinogenicity, that could result from exposure to fluazinam.  The fluazinam doses and endpoints for use in dietary exposure assessments are summarized in Table 3.

Table 3.  Toxicological Doses and Endpoints for Fluazinam for Use in Dietary and Non-Occupational Human Health Risk Assessments
Exposure/
Scenario
Point of Departure
Uncertainty/
FQPA Safety Factors
RfD, PAD, Level of Concern for Risk Assessment
Study and Toxicological Effects
Acute Dietary (General population)
NOAEL= 50 mg/kg/day

UFA= 10x
UFH=10x
FQPA SF=1x

Acute RfD =0.5 mg/kg/day

aPAD
= 0.5mg/kg/day
Acute Neurotoxicity-Rats
LOAEL = 1000 mg/kg/day based on decreased motor activity and soft stools on day of dosing.
Acute Dietary
(Females 13-49 years of age)
NOAEL (developmental) = 7 mg/kg/day
UFA= 10x
UFH=10x
FQPA SF=1x

Acute RfD =0.07 mg/kg/day

aPAD
= 0.07mg/kg/day
Developmental Toxicity- Rabbits
Developmental LOAEL = 12 mg/kg/day based on increased incidence of total litter resorptions and possibly increased incidence of fetal skeletal abnormalities.
Chronic Dietary (All Populations)
NOAEL= 1.1 mg/kg/day

UFA= 10x
UFH=10x
FQPA SF=1x

Chronic RfD =0.011 mg/kg/day

cPAD
= 0.011mg/kg/day
Carcinogenicity-Mice
LOAEL = 10.7 mg/kg/day based on liver histopathology and increased liver weight.
Cancer (oral, dermal, inhalation)
Classification: "Suggestive Evidence of Carcinogenicity, but not sufficient to assess human carcinogenic potential."
	NOAEL = no observed adverse effect level.  LOAEL = lowest observed adverse effect level.  UF = uncertainty factor.  UFA = extrapolation from animal to human (interspecies).  UFH = potential variation in sensitivity among members of the human population (intraspecies). FQPA SF = FQPA Safety Factor.  PAD = population adjusted dose (a = acute, c = chronic).  RfD = reference dose.

VII.   Results/Discussion

As stated above, for acute and chronic assessments, HED is concerned when dietary risk exceeds 100% of the PAD.  The DEEM-FCID(TM) analyses estimate the dietary exposure of the U.S. population and various population subgroups.  The results reported in Table 4 are for the general U.S. Population, all infants (<1 year old), children 1-2, children 3-5, children 6-12, youth 13-19, females 13-49, adults 20-49, and adults 50-99 years.  Risk estimates are below HED's level of concern for all population subgroups in both the acute and chronic analyses.  The acute risk estimate for the general U.S. population is 5.3% of the aPAD.  The population subgroup with the highest acute risk estimate is Females 13-49, which uses 28% of the aPAD.  Although Females 13-49 use the greatest percent of the aPAD, the population subgroup with the highest exposure is Children 1-2.  Children 1-2 uses 21% of the aPAD.  The reason this subgroup has a higher exposure but a lower % aPAD value than Females 13-49 is that it has a higher aPAD value than Females 13-49 (0.5 mg/kg/day for Children 1-2 as opposed to 0.07 mg/kg/day for Females 13-49).
The chronic risk estimate for the general U.S. population is 20% of the cPAD.  The most highly exposed population subgroup is Children 1-2, which uses 51% of the cPAD.  Finally, cancer risk is not of concern.

 Full listings of exposure and risk estimates are included in Attachments 2 (acute analysis) and 4 (chronic analysis).

 Table 4.  Summary of Acute and Chronic Exposure and Risk Estimates for Fluazinam
                              Population Subgroup
                      Acute Assessment (95[th] Percentile)
                               Chronic Assessment

                                aPAD, mg/kg/day
                          Exposure Estimate, mg/kg/day
                                     % aPAD
                                cPAD, mg/kg/day
                          Exposure Estimate, mg/kg/day
                                     % cPAD
U.S. Population
0.5
0.026393
5.3
                                     0.011
0.002145
20
All infants
0.5
0.083776
17
                                     0.011
0.004928
45
Children 1-2 yrs*
0.5
0.106710
21
                                     0.011
0.005635
51
Children 3-5 yrs
0.5
0.064022
13
                                     0.011
0.003751
34
Children 6-12 yrs
0.5
0.031323
6.3
                                     0.011
0.002031
18
Youth 13-19 yrs
0.5
0.017332
3.5
                                     0.011
0.001171
11
Adults 20-49 yrs
0.5
0.019148
3.8
                                     0.011
0.001936
18
Adults 50-99 yrs
0.5
0.017495
3.5
                                     0.011
0.002118
19
Females 13-49 yrs*
0.07
0.019721
28
                                     0.011
0.001996
18
 *The subpopulation with the highest acute or chronic risk estimate

 VIII.   Characterization of Inputs/Outputs

HED considers both the acute and chronic assessments to be very conservative.  The acute assessment is based on tolerance-level residues for all commodities, with worst-case assumptions being made for residue levels of the metabolite AMGT.  In addition, it was assumed that 100% of all crops with registered or requested uses of fluazinam will be treated.  The EDWCs include parent fluazinam and its transformation products.  The assumption was made that the degradates were as toxic as parent fluazinam.  These same assumptions and inputs were used for the chronic assessment, except that an average field trial value was used for apples.  These assumptions result in highly conservative, health-protective estimates of exposure and risk.  In the event that refinements need to be made in the future, percent crop treated estimates, average field trial values, and monitoring data can be incorporated into the assessments.

 IX.   Conclusions

 The exposure estimates generated by the dietary exposure model that was used are conservative estimates of dietary exposure.  Even so, the acute and chronic aggregate (food + drinking water) dietary risk estimates for the general U.S. population and all population subgroups are not of concern.  The chronic dietary exposure assessment is protective for cancer.  Cancer risk is also not of concern.

 X.   List of Attachments

Attachment 1.  Acute Dietary Residue Input File for Fluazinam
Attachment 2.  Results of Acute Dietary Exposure Assessment
 Attachment 3.  Chronic Dietary Residue Input File for Fluazinam
 Attachment 4.  Results of Chronic Dietary Exposure Assessment

Attachment 1:  Acute Dietary Residue Input File for Fluazinam

DEEM FCID Version 3.16

Acute NOAEL for general population including infants and children:  50 mg/kg bw/day
Acute PAD for general population including infants and children:  0.5 mg/kg bw/day

Acute NOAEL for Females 13-49:  7 mg/kg bw/day
Acute PAD for Females 13-49:  0.07 mg/kg bw/day

Filename: C:\Documents and Settings\ddotson\My Documents\DEEM FCID\Fluazinam\
                 Fluazinam2012acute.R08
Date created/last modified: 07-14-2012/11:50:12

-----------------------------------------------------------------------------------
   EPA     Crop                                   Def Res     Adj.Factors   Comment
   Code     Grp  Commodity Name                    (ppm)       #1    #2
---------- ---- -------------------------------  ----------  ------ ------  -------
0101078000 1AB  Carrot                             0.700000   1.000  1.000
0101078001 1AB  Carrot-babyfood                    0.700000   1.000  1.000
0101079000 1AB  Carrot, juice                      0.700000   1.000  1.000
0101168000 1AB  Ginseng, dried                     4.500000   1.000  1.000
0103296000 1C   Potato, chips                      0.020000   1.000  1.000
0103297000 1C   Potato, dry (granules/ flakes)     0.020000   6.500  1.000
0103297001 1C   Potato, dry (granules/ flakes)-b   0.020000   6.500  1.000
0103298000 1C   Potato, flour                      0.020000   6.500  1.000
0103298001 1C   Potato, flour-babyfood             0.020000   6.500  1.000
0103299000 1C   Potato, tuber, w/peel              0.020000   1.000  1.000
0103299001 1C   Potato, tuber, w/peel-babyfood     0.020000   1.000  1.000
0103300000 1C   Potato, tuber, w/o peel            0.020000   1.000  1.000
0103300001 1C   Potato, tuber, w/o peel-babyfood   0.020000   1.000  1.000
0301165000 3A   Garlic, bulb                       0.200000   1.000  1.000
0301165001 3A   Garlic, bulb-babyfood              0.200000   1.000  1.000
0301237000 3A   Onion, bulb                        0.200000   1.000  1.000
0301237001 3A   Onion, bulb-babyfood               0.200000   1.000  1.000
0301238000 3A   Onion, bulb, dried                 0.200000   9.000  1.000
0301238001 3A   Onion, bulb, dried-babyfood        0.200000   9.000  1.000
0302338500 3B   Shallot, fresh leaves              0.200000   1.000  1.000
0401204000 4A   Lettuce, head                      0.027000   1.000  1.000
0401205000 4A   Lettuce, leaf                      2.700000   1.000  1.000
0501061000 5A   Broccoli                           0.013500   1.000  1.000
0501061001 5A   Broccoli-babyfood                  0.013500   1.000  1.000
0501062000 5A   Broccoli, Chinese                  0.013500   1.000  1.000
0501064000 5A   Brussels sprouts                   0.013500   1.000  1.000
0501069000 5A   Cabbage                            0.013500   1.000  1.000
0501071000 5A   Cabbage, Chinese, napa             0.013500   1.000  1.000
0501072000 5A   Cabbage, Chinese, mustard          0.013500   1.000  1.000
0501083000 5A   Cauliflower                        0.013500   1.000  1.000
0501196000 5A   Kohlrabi                           0.013500   1.000  1.000
0502063000 5B   Broccoli raab                      0.013500   1.000  1.000
0502070000 5B   Cabbage, Chinese, bok choy         0.013500   1.000  1.000
0502117000 5B   Collards                           0.013500   1.000  1.000
0502194000 5B   Kale                               0.013500   1.000  1.000
0502229000 5B   Mustard greens                     0.013500   1.000  1.000
0502318000 5B   Rape greens                        0.013500   1.000  1.000
0502389000 5B   Turnip, greens                     0.013500   1.000  1.000
0600347000 6    Soybean, seed                      0.020000   1.000  1.000
0600349000 6    Soybean, soy milk                  0.020000   1.000  1.000
0600349001 6    Soybean, soy milk-babyfood or in   0.020000   1.000  1.000
0600350000 6    Soybean, oil                       0.020000   1.000  1.000
0600350001 6    Soybean, oil-babyfood              0.020000   1.000  1.000
0601043000 6A   Bean, snap, succulent              0.135000   1.000  1.000
0601043001 6A   Bean, snap, succulent-babyfood     0.135000   1.000  1.000
0602031000 6B   Bean, broad, succulent             0.054000   1.000  1.000
0602033000 6B   Bean, cowpea, succulent            0.054000   1.000  1.000
0602037000 6B   Bean, lima, succulent              0.054000   1.000  1.000
0603030000 6C   Bean, black, seed                  0.027000   1.000  1.000
0603032000 6C   Bean, broad, seed                  0.027000   1.000  1.000
0603034000 6C   Bean, cowpea, seed                 0.027000   1.000  1.000
0603035000 6C   Bean,  great northern, seed        0.027000   1.000  1.000
0603036000 6C   Bean, kidney, seed                 0.027000   1.000  1.000
0603038000 6C   Bean, lima, seed                   0.027000   1.000  1.000
0603039000 6C   Bean, mung, seed                   0.027000   1.000  1.000
0603040000 6C   Bean, navy, seed                   0.027000   1.000  1.000
0603041000 6C   Bean, pink, seed                   0.027000   1.000  1.000
0603042000 6C   Bean, pinto, seed                  0.027000   1.000  1.000
0603098000 6C   Chickpea, seed                     0.027000   1.000  1.000
0603098001 6C   Chickpea, seed-babyfood            0.027000   1.000  1.000
0603099000 6C   Chickpea, flour                    0.027000   1.000  1.000
0603182000 6C   Guar, seed                         0.027000   1.000  1.000
0603182001 6C   Guar, seed-babyfood                0.027000   1.000  1.000
0802148000 8BC  Eggplant                           0.100000   1.000  1.000
0802234000 8BC  Okra                               0.100000   1.000  1.000
0802270000 8B   Pepper, bell                       0.100000   1.000  1.000
0802270001 8B   Pepper, bell-babyfood              0.100000   1.000  1.000
0802271000 8B   Pepper, bell, dried                0.100000   1.000  1.000
0802271001 8B   Pepper, bell, dried-babyfood       0.100000   1.000  1.000
0802272000 8BC  Pepper, nonbell                    0.100000   1.000  1.000
0802272001 8BC  Pepper, nonbell-babyfood           0.100000   1.000  1.000
0802273000 8BC  Pepper, nonbell, dried             0.100000   1.000  1.000
0901075000 9A   Cantaloupe                         0.080000   1.000  1.000
0901187000 9A   Honeydew melon                     0.080000   1.000  1.000
0901399000 9A   Watermelon                         0.080000   1.000  1.000
0901400000 9A   Watermelon, juice                  0.080000   1.000  1.000
1100007000 11   Apple, fruit with peel             2.000000   1.000  1.000
1100008000 11   Apple, peeled fruit                2.000000   1.000  1.000
1100008001 11   Apple, peeled fruit-babyfood       2.000000   1.000  1.000
1100009000 11   Apple, dried                       2.000000   8.000  1.000
1100009001 11   Apple, dried-babyfood              2.000000   8.000  1.000
1100010000 11   Apple, juice                       2.000000   1.300  1.000
1100010001 11   Apple, juice-babyfood              2.000000   1.300  1.000
1100011000 11   Apple, sauce                       2.000000   1.000  1.000
1100011001 11   Apple, sauce-babyfood              2.000000   1.000  1.000
1302057000 13B  Blueberry                          7.800000   1.000  1.000
1302057001 13B  Blueberry-babyfood                 7.800000   1.000  1.000
1302136000 13B  Currant                            7.800000   1.000  1.000
1302137000 13B  Currant, dried                     7.800000   1.000  1.000
1302149000 13B  Elderberry                         7.800000   1.000  1.000
1302174000 13B  Gooseberry                         7.800000   1.000  1.000
1302191000 13B  Huckleberry                        7.800000   1.000  1.000
1304179000 13D  Grape, wine and sherry             3.000000   1.000  1.000
3100046000 31   Beef, meat byproducts              0.050000   1.000  1.000
3100046001 31   Beef, meat byproducts-babyfood     0.050000   1.000  1.000
3100047000 31   Beef, fat                          0.050000   1.000  1.000
3100047001 31   Beef, fat-babyfood                 0.050000   1.000  1.000
3100048000 31   Beef, kidney                       0.050000   1.000  1.000
3100049000 31   Beef, liver                        0.050000   1.000  1.000
3100049001 31   Beef, liver-babyfood               0.050000   1.000  1.000
3200170000 32   Goat, meat byproducts              0.050000   1.000  1.000
3200171000 32   Goat, fat                          0.050000   1.000  1.000
3200172000 32   Goat, kidney                       0.050000   1.000  1.000
3200173000 32   Goat, liver                        0.050000   1.000  1.000
3500340000 35   Sheep, meat byproducts             0.050000   1.000  1.000
3500341000 35   Sheep, fat                         0.050000   1.000  1.000
3500341001 35   Sheep, fat-babyfood                0.050000   1.000  1.000
3500342000 35   Sheep, kidney                      0.050000   1.000  1.000
3500343000 35   Sheep, liver                       0.050000   1.000  1.000
8601000000 86A  Water, direct, all sources         0.226000   1.000  1.000
8602000000 86B  Water, indirect, all sources       0.226000   1.000  1.000
9500263000 O    Peanut                             0.020000   1.000  1.000
9500264000 O    Peanut, butter                     0.020000   1.890  1.000
9500265000 O    Peanut, oil                        0.020000   1.000  1.000

Attachment 2:  Results of Acute Dietary Exposure Assessment

Residue file:  Fluazinam2012acute.R08
Analysis Date:  07-14-2012/13:18:43
Residue file dated:  07-14-2012/13:14:55

Acute PAD for general population including infants and children:  0.5 mg/kg bw/day
Acute PAD for Females 13-49:  0.07 mg/kg bw/day

===============================================================================

Summary calculations--per capita:

                   95th Percentile      99th Percentile     99.9th Percentile
                   Exposure   % aPAD    Exposure   % aPAD    Exposure   % aPAD
                  ---------- --------  ---------- --------  ---------- --------
US Population:      0.026393     5.28    0.061603    12.32    0.149939    29.99

All Infants:        0.083776    16.76    0.147293    29.46    0.211463    42.29

Children 1-2:       0.106710    21.34    0.189491    37.90    0.308126    61.63

Children 3-5:       0.064022    12.80    0.115100    23.02    0.175905    35.18

Children 6-12:      0.031323     6.26    0.065217    13.04    0.118435    23.69

Youth 13-19:        0.017332     3.47    0.029815     5.96    0.054124    10.82

Adults 20-49:       0.019148     3.83    0.031090     6.22    0.066911    13.38

Adults 50-99:       0.017495     3.50    0.027960     5.59    0.044332     8.87

Female 13-49:       0.019721    28.17    0.031934    45.62    0.067067    95.81

===============================================================================

Attachment 3:  Chronic Dietary Residue Input File for Fluazinam

DEEM FCID Version 3.16

Chronic NOAEL:  1.1 mg/kg bw/day
Chronic PAD:       0.011 mg/kg bw/day

Filename: C:\Documents and Settings\ddotson\My Documents\ DEEMFCID\Fluazinam \Fluazinam2012chronic.R08

Date created/last modified: 07-14-2012/13:13:47

-----------------------------------------------------------------------------------
   EPA     Crop                                   Def Res     Adj.Factors   Comment
   Code     Grp  Commodity Name                    (ppm)       #1    #2
---------- ---- -------------------------------  ----------  ------ ------  -------
0101078000 1AB  Carrot                             0.700000   1.000  1.000
0101078001 1AB  Carrot-babyfood                    0.700000   1.000  1.000
0101079000 1AB  Carrot, juice                      0.700000   1.000  1.000
0101168000 1AB  Ginseng, dried                     4.500000   1.000  1.000
0103296000 1C   Potato, chips                      0.020000   1.000  1.000
0103297000 1C   Potato, dry (granules/ flakes)     0.020000   6.500  1.000
0103297001 1C   Potato, dry (granules/ flakes)-b   0.020000   6.500  1.000
0103298000 1C   Potato, flour                      0.020000   6.500  1.000
0103298001 1C   Potato, flour-babyfood             0.020000   6.500  1.000
0103299000 1C   Potato, tuber, w/peel              0.020000   1.000  1.000
0103299001 1C   Potato, tuber, w/peel-babyfood     0.020000   1.000  1.000
0103300000 1C   Potato, tuber, w/o peel            0.020000   1.000  1.000
0103300001 1C   Potato, tuber, w/o peel-babyfood   0.020000   1.000  1.000
0301165000 3A   Garlic, bulb                       0.200000   1.000  1.000
0301165001 3A   Garlic, bulb-babyfood              0.200000   1.000  1.000
0301237000 3A   Onion, bulb                        0.200000   1.000  1.000
0301237001 3A   Onion, bulb-babyfood               0.200000   1.000  1.000
0301238000 3A   Onion, bulb, dried                 0.200000   9.000  1.000
0301238001 3A   Onion, bulb, dried-babyfood        0.200000   9.000  1.000
0302338500 3B   Shallot, fresh leaves              0.200000   1.000  1.000
0401204000 4A   Lettuce, head                      0.027000   1.000  1.000
0401205000 4A   Lettuce, leaf                      2.700000   1.000  1.000
0501061000 5A   Broccoli                           0.013500   1.000  1.000
0501061001 5A   Broccoli-babyfood                  0.013500   1.000  1.000
0501062000 5A   Broccoli, Chinese                  0.013500   1.000  1.000
0501064000 5A   Brussels sprouts                   0.013500   1.000  1.000
0501069000 5A   Cabbage                            0.013500   1.000  1.000
0501071000 5A   Cabbage, Chinese, napa             0.013500   1.000  1.000
0501072000 5A   Cabbage, Chinese, mustard          0.013500   1.000  1.000
0501083000 5A   Cauliflower                        0.013500   1.000  1.000
0501196000 5A   Kohlrabi                           0.013500   1.000  1.000
0502063000 5B   Broccoli raab                      0.013500   1.000  1.000
0502070000 5B   Cabbage, Chinese, bok choy         0.013500   1.000  1.000
0502117000 5B   Collards                           0.013500   1.000  1.000
0502194000 5B   Kale                               0.013500   1.000  1.000
0502229000 5B   Mustard greens                     0.013500   1.000  1.000
0502318000 5B   Rape greens                        0.013500   1.000  1.000
0502389000 5B   Turnip, greens                     0.013500   1.000  1.000
0600347000 6    Soybean, seed                      0.020000   1.000  1.000
0600349000 6    Soybean, soy milk                  0.020000   1.000  1.000
0600349001 6    Soybean, soy milk-babyfood or in   0.020000   1.000  1.000
0600350000 6    Soybean, oil                       0.020000   1.000  1.000
0600350001 6    Soybean, oil-babyfood              0.020000   1.000  1.000
0601043000 6A   Bean, snap, succulent              0.135000   1.000  1.000
0601043001 6A   Bean, snap, succulent-babyfood     0.135000   1.000  1.000
0602031000 6B   Bean, broad, succulent             0.054000   1.000  1.000
0602033000 6B   Bean, cowpea, succulent            0.054000   1.000  1.000
0602037000 6B   Bean, lima, succulent              0.054000   1.000  1.000
0603030000 6C   Bean, black, seed                  0.027000   1.000  1.000
0603032000 6C   Bean, broad, seed                  0.027000   1.000  1.000
0603034000 6C   Bean, cowpea, seed                 0.027000   1.000  1.000
0603035000 6C   Bean,  great northern, seed        0.027000   1.000  1.000
0603036000 6C   Bean, kidney, seed                 0.027000   1.000  1.000
0603038000 6C   Bean, lima, seed                   0.027000   1.000  1.000
0603039000 6C   Bean, mung, seed                   0.027000   1.000  1.000
0603040000 6C   Bean, navy, seed                   0.027000   1.000  1.000
0603041000 6C   Bean, pink, seed                   0.027000   1.000  1.000
0603042000 6C   Bean, pinto, seed                  0.027000   1.000  1.000
0603098000 6C   Chickpea, seed                     0.027000   1.000  1.000
0603098001 6C   Chickpea, seed-babyfood            0.027000   1.000  1.000
0603099000 6C   Chickpea, flour                    0.027000   1.000  1.000
0603182000 6C   Guar, seed                         0.027000   1.000  1.000
0603182001 6C   Guar, seed-babyfood                0.027000   1.000  1.000
0802148000 8BC  Eggplant                           0.100000   1.000  1.000
0802234000 8BC  Okra                               0.100000   1.000  1.000
0802270000 8B   Pepper, bell                       0.100000   1.000  1.000
0802270001 8B   Pepper, bell-babyfood              0.100000   1.000  1.000
0802271000 8B   Pepper, bell, dried                0.100000   1.000  1.000
0802271001 8B   Pepper, bell, dried-babyfood       0.100000   1.000  1.000
0802272000 8BC  Pepper, nonbell                    0.100000   1.000  1.000
0802272001 8BC  Pepper, nonbell-babyfood           0.100000   1.000  1.000
0802273000 8BC  Pepper, nonbell, dried             0.100000   1.000  1.000
0901075000 9A   Cantaloupe                         0.080000   1.000  1.000
0901187000 9A   Honeydew melon                     0.080000   1.000  1.000
0901399000 9A   Watermelon                         0.080000   1.000  1.000
0901400000 9A   Watermelon, juice                  0.080000   1.000  1.000
1100007000 11   Apple, fruit with peel             0.215000   1.000  1.000
1100008000 11   Apple, peeled fruit                0.215000   1.000  1.000
1100008001 11   Apple, peeled fruit-babyfood       0.215000   1.000  1.000
1100009000 11   Apple, dried                       0.215000   8.000  1.000
1100009001 11   Apple, dried-babyfood              0.215000   8.000  1.000
1100010000 11   Apple, juice                       0.215000   1.300  1.000
1100010001 11   Apple, juice-babyfood              0.215000   1.300  1.000
1100011000 11   Apple, sauce                       0.215000   1.000  1.000
1100011001 11   Apple, sauce-babyfood              0.215000   1.000  1.000
1302057000 13B  Blueberry                          7.800000   1.000  1.000
1302057001 13B  Blueberry-babyfood                 7.800000   1.000  1.000
1302136000 13B  Currant                            7.800000   1.000  1.000
1302137000 13B  Currant, dried                     7.800000   1.000  1.000
1302149000 13B  Elderberry                         7.800000   1.000  1.000
1302174000 13B  Gooseberry                         7.800000   1.000  1.000
1302191000 13B  Huckleberry                        7.800000   1.000  1.000
1304179000 13D  Grape, wine and sherry             3.000000   1.000  1.000
3100046000 31   Beef, meat byproducts              0.050000   1.000  1.000
3100046001 31   Beef, meat byproducts-babyfood     0.050000   1.000  1.000
3100047000 31   Beef, fat                          0.050000   1.000  1.000
3100047001 31   Beef, fat-babyfood                 0.050000   1.000  1.000
3100048000 31   Beef, kidney                       0.050000   1.000  1.000
3100049000 31   Beef, liver                        0.050000   1.000  1.000
3100049001 31   Beef, liver-babyfood               0.050000   1.000  1.000
3200170000 32   Goat, meat byproducts              0.050000   1.000  1.000
3200171000 32   Goat, fat                          0.050000   1.000  1.000
3200172000 32   Goat, kidney                       0.050000   1.000  1.000
3200173000 32   Goat, liver                        0.050000   1.000  1.000
3500340000 35   Sheep, meat byproducts             0.050000   1.000  1.000
3500341000 35   Sheep, fat                         0.050000   1.000  1.000
3500341001 35   Sheep, fat-babyfood                0.050000   1.000  1.000
3500342000 35   Sheep, kidney                      0.050000   1.000  1.000
3500343000 35   Sheep, liver                       0.050000   1.000  1.000
8601000000 86A  Water, direct, all sources         0.037800   1.000  1.000
8602000000 86B  Water, indirect, all sources       0.037800   1.000  1.000
9500263000 O    Peanut                             0.020000   1.000  1.000
9500264000 O    Peanut, butter                     0.020000   1.890  1.000
9500265000 O    Peanut, oil                        0.020000   1.000  1.000

Attachment 4:  Results of Chronic Dietary Exposure Assessment

Residue file name: C:\Documents and Settings\ddotson\My Documents\Deemfcid\
                Fluazinam2011\Fluazinam2011chronic.R98

Residue file dated: 07-14-2012/13:13:47
Analysis Date:  07-14-2012/13:16:45

Residue file name: C:\Documents and Settings\ddotson\My Documents\DEEM FCID\Fluazinam \Fluazinam2012chronic.R08

===============================================================================
                    Total exposure by population subgroup
-------------------------------------------------------------------------------

                                                    Total Exposure
                                         -----------------------------------
          Population                         mg/kg             Percent of
           Subgroup                       body wt/day             cPAD
--------------------------------------   -------------       ----------------
Total US Population                         0.002145                19.5%
Hispanic                                    0.001795                16.3%
Non-Hisp-White                              0.002318                21.1%
Non-Hisp-Black                              0.001494                13.6%
Non-Hisp-Other                              0.002299                20.9%
Nursing Infants                             0.002550                23.2%
Non-Nursing Infants                         0.005990                54.5%
Female 13+ PREG                             0.001372                12.5%
Children 1-6                                0.004298                39.1%
Children 7-12                               0.001856                16.9%
Male 13-19                                  0.001150                10.5%
Female 13-19/NP                             0.001192                10.8%
Male 20+                                    0.001756                16.0%
Female 20+/NP                               0.002268                20.6%
Seniors 55+                                 0.002145                19.5%
All Infants                                 0.004928                44.8%
Female 13-50                                0.002002                18.2%
Children 1-2                                0.005635                51.2%
Children 3-5                                0.003751                34.1%
Children 6-12                               0.002031                18.5%
Youth 13-19                                 0.001171                10.6%
Adults 20-49                                0.001936                17.6%
Adults 50-99                                0.002118                19.3%
Female 13-49                                0.001996                18.1%

-------------------------------------------------------------------------------


[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Pages 64166-64167]
[FR Doc No: 2018-27018]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-84761; File No. SR-NYSE-2011-55]

Self-Regulatory Organizations; New York Stock Exchange LLC; Order
Granting an Extension to Limited Exemptions From Rule 612(c) of
Regulation NMS in Connection With the Exchange's Retail Liquidity
Program Until June 30, 2019

December 10, 2018.
    On July 3, 2012, the Securities and Exchange Commission
(``Commission'') issued an order pursuant to its authority under Rule
612(c) of Regulation NMS (``Sub-Penny Rule'') \1\ that granted the New
York Stock Exchange LLC (``NYSE'') a limited exemption from the Sub-
Penny Rule in connection with the operation of the Exchange's Retail
Liquidity Program (``Program'').\2\ The limited exemption was granted
concurrently with the Commission's approval of the Exchange's proposal
to adopt its Program for a one-year pilot term.\3\ The exemption was
granted coterminous with the effectiveness of the pilot Program; both
the pilot Program and exemption are scheduled to expire on December 31,
2018.\4\
---------------------------------------------------------------------------

    \1\ 17 CFR 242.612(c).
    \2\ See Securities Exchange Act Release No. 67347 (July 3,
2012), 77 FR 40673 (July 10, 2012) (SR-NYSE-2011-55; SR-NYSEAmex-
2011-84) (``Order'').
    \3\ See id.
    \4\ On July 30, 2013, the Exchange requested an extension of the
exemption for the Program. See Letter from Janet McGinness, SVP and
Corporate Secretary, NYSE Euronext, to Elizabeth M. Murphy,
Secretary, Commission, dated July 30, 2013. The pilot period for the
Program was extended until July 31, 2014. See Securities Exchange
Act Release No. 70096 (August 2, 2013), 78 FR 48520 (August 8, 2013)
(SR-NYSE-2013-48). On July 30, 2014, the Exchange requested another
extension of the exemption for the Program. See Letter from Martha
Redding, Chief Counsel, NYSE, to Kevin M O'Neill, Deputy Secretary,
Commission, dated July 30, 2014. The pilot period for the Program
was extended until March 31, 2015. See Securities Exchange Act
Release No. 72629 (July 16, 2014), 79 FR 42564 (July 22, 2014) (SR-
NYSE-2014-35). On February 27, 2015, the Exchange requested another
extension of the exemption for the Program. See Letter from Martha
Redding, Senior Counsel, NYSE, to Brent J. Fields, Secretary,
Commission, dated February 27, 2015. The pilot period for the
Program was extended until September 30, 2015. See Securities
Exchange Act Release No. 74454 (March 6, 2015), 80 FR 13054 (March
12, 2015) (SR-NYSE-2015-10). On September 17, 2015, the Exchange
requested another extension of the exemption for the Program. See
Letter from Martha Redding, Senior Counsel, NYSE, to Brent J.
Fields, Secretary, Commission, dated September 17, 2015. The pilot
period for the Program was extended until March 31, 2016. See
Securities Exchange Act Release No. 75993 (September 28, 2015), 80
FR 59844 (October 2, 2015) (SR-NYSE-2015-41). On March 17, 2016, the
Exchange requested another extension of the exemption for the
Program. See Letter from Martha Redding, Senior Counsel, NYSE, to
Brent J. Fields, Secretary, Commission, dated March 17, 2016. The
pilot period for the Program was extended until August 31, 2016. See
Securities Exchange Act Release No. 77426 (March 23, 2016), 81 FR
17533 (March 29, 2016) (SR-NYSE-2016-25). On August 8, 2016, the
Exchange requested another extension of the exemption for the
Program. See Letter from Martha Redding, Associate General Counsel,
NYSE, to Brent J. Fields, Secretary, Commission, dated August 8,
2016. The pilot period for the Program was extended until December
31, 2016. See Securities Exchange Act Release No. 78600 (August 17,
2016), 81 FR 57642 (August 23, 2016) (SR-NYSE-2016-54). On November
28, 2016, the Exchange requested another extension of the exemption
for the Program. See Letter from Martha Redding, Associate General
Counsel, NYSE, to Brent J. Fields, Secretary, Commission, dated
November 28, 2016. The pilot period for the Program was extended
until June 30, 2017. See Securities Exchange Act Release No.79493
(December 7, 2016), 81 FR 90019 (December 13, 2016) (SR-NYSE-2016-
82). On May 23, 2017, the Exchange requested another extension of
the exemption for the Program. See Letter from Martha Redding,
Associate General Counsel, NYSE, to Brent J. Fields, Secretary,
Commission, dated May 23, 2017. The pilot period for the Program was
extended until December 31, 2017. See Securities Exchange Act
Release No. 80844 (June 1, 2017), 82 FR 26562 (June 7, 2017) (SR-
NYSE-2017-26). On November 30, 2017, the Exchange requested another
extension of the exemption for the Program. See Letter from Martha
Redding, Assistant Secretary, NYSE, to Brent J. Fields, Secretary,
Commission, dated November 30, 2017. The pilot period for the
Program was extended until June 30, 2018. See Securities Exchange
Act Release No. 82230 (December 7, 2017), 82 FR 58667 (December 13,
2017) (SR-NYSE-2017-64). On June 14, 2018, the Exchange requested
another extension of the exemption for the Program. See Letter from
Martha Redding, Associate General Counsel and Assistant Secretary,
NYSE to Brent J. Fields, Secretary, Commission, dated June 14, 2018.
The pilot period for the Program was extended until December 31,
2018. See Securities Exchange Act Release No. 83540 (June 28, 2018),
83 FR 31234 (July 3, 2018) (SR-NYSE-2018-29).
---------------------------------------------------------------------------

    The Exchange now seeks a six month extension of the exemption,
which would be until June 30, 2019.\5\ The Exchange's request was made
in

conjunction with an immediately effective filing that extends the
operation of the Program through the same date.\6\ In its request to
extend the exemption, the Exchange notes that the participation in the
Program has increased more recently with additional Retail Liquidity
Providers. Accordingly, the Exchange has asked for additional time to
both allow for additional opportunities for greater participation in
the Program and allow for further assessment of the results of such
participation. For this reason and the reasons stated in the Order
originally granting the limited exemptions, the Commission finds that
extending the exemption, pursuant to its authority under Rule 612(c) of
Regulation NMS, is appropriate in the public interest and consistent
with the protection of investors.
---------------------------------------------------------------------------

    \5\ See Letter from Martha Redding, Associate General Counsel
and Assistant Secretary, NYSE to Brent J. Fields, Secretary,
Commission, dated November 30, 2018, at 1.
    \6\ See SR-NYSE-2018-59.
---------------------------------------------------------------------------

    Therefore, it is hereby ordered that, pursuant to Rule 612(c) of
Regulation NMS, the Exchange is granted a limited exemption from Rule
612 of Regulation NMS that allows it to accept and rank orders priced
equal to or greater than $1.00 per share in increments of $0.001, in
connection with the operation of its Retail Liquidity Program, until
June 30, 2019.
    The limited and temporary exemption extended by this Order is
subject to modification or revocation if at any time the Commission
determines that such action is necessary or appropriate in furtherance
of the purposes of the Securities Exchange Act of 1934. Responsibility
for compliance with any applicable provisions of the Federal securities
laws must rest with the persons relying on the exemptions that are the
subject of this Order.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\7\
---------------------------------------------------------------------------

    \7\ 17 CFR 200.30-3(a)(83).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Deputy Secretary.
[FR Doc. 2018-27018 Filed 12-12-18; 8:45 am]
BILLING CODE 8011-01-P


 Oxytetracycline Reader's Guide 1 Reader's Guide to Streptomycin E Docket # EPA HQ OPP 2005 0493 EPA has created this document to provide an organizational structure to the Streptomycin E Docket. The docket index groups related documents. The Agency is providing this " Reader's Guide" to allow the reader to more easily access and navigate the items contained in the streptomycin e docket.

Federal Register and Docket Organizational Documents:

Docket Item 1. Federal Register Notice: Streptomycin Risk Assessment( s), Notice of Availability, and Risk Reduction Options ( Phase 3 of 4 Phase Process)

This document formally and publicly announces the streptomycin risk assessments are available for review on the internet or at the EPA's Office of Pesticides Programs' Public Docket and solicits comments and suggestions on the risk assessments and how to mitigate or address potential risks of concern.

Docket Item 2. Reader's Guide to the streptomycin E Docket # EPA HQ OPP 2005 0493.

This document. It is designed to annotate all the documents in the streptomycin E Docket.

Docket Item 3. Meeting Summary Antibiotic Resistance Conference Calls This 1 page document summarizes two May 2005 conference calls EPA hosted with US Centers for Disease Control and Prevention ( CDC), US Food and Drug Administration ( FDA), and US Department of Agriculture ( USDA) to discuss the potential for oxytetracycline and streptomycin to contribute to antibiotic resistance. The document includes a list of participants, a summary of topics discussed, and, if appropriate, next steps and/ or action items.

Docket Item 4. Meeting Summary EPA/ FDA Streptomycin and Oxytetracycline Phase 1 Conference Call This 2 page document summarizes a December 2005 conference call EPA hosted with FDA to discuss FDA's comments on the preliminary ( Phase 1) streptomycin and oxytetracycline risk assessments. The document includes a list of participants, a summary of topics discussed, and, if appropriate, next steps and/ or action items. Oxytetracycline Reader's Guide 2 Human Health Risk Assessment Documents for Phase 3 Public Comments Docket Item 5. Meeting Summary  EPA/ CDC Streptomycin and Oxytetracycline Phase 1 Conference Call This 1 page document summarizes a November 2005 conference call EPA hosted with CDC to discuss CDC's comments on the preliminary ( Phase 1) streptomycin and oxytetracycline risk assessments. The document includes a list of participants, a summary of topics discussed, and, if appropriate, next steps and/ or action items.

Docket Item 6. Meeting Minutes Streptomycin TRED SMART Meeting This 3 page document summarizes a January 2005 SMART meeting EPA hosted with the streptomycin technical registrants, CDC, FDA, and USDA to discuss use, usage, scheduling, and other issues in preparation. The document includes a list of participants, a summary of topics discussed, and, if appropriate, next steps and/ or action items.

Docket Item 7. Tier I Estimated Drinking Water Concentrations of Streptomycin and StreptomycinSulfate for use in the Human Health Risk Assessment as part of the Tolerance Reregistration Eligibility Decision ( TRED)

This 41 page November 2005 document describes how much streptomycin may be found in drinking water after application in the field.

Docket Item 8. Streptomycin/ Streptomycin Sulfate: Chronic Dietary Exposure Assessment for the Tolerance Reassessment Eligibility Decision ( TRED)

This 18 page January 2006 document reports the estimated dietary exposure resulting from applications of oxytetracycline to crops.

Docket Item 9: Review of Streptomycin Incident Reports This 4 page August 2005 memorandum gives a summary of the poisoning incident data on the active ingredient streptomycin.

Docket Item 10: Streptomycin and Streptomycin Sulfate Use Closure Memo This 11 page March 2005 memorandum outlines the uses and application rates of streptomycin that were to be used in the preliminary risk assessments. Oxytetracycline Reader's Guide 3 Docket Item 11: STREPTOMYCIN SULFATE ( 006310) and STREPTOMYCIN ( 006306) HED Chapter of the Tolerance Reassessment Eligibility Document ( TRED)

This 2006 document reports the potential risk from dietary and other exposure to oxytetracycline and includes a qualitative discussion of the potential contribution to antibiotic resistance.

Docket Item 12: Issues to Consider in Commenting on the Preliminary Risk Assessments for Streptomycin ( Case Number 0169) and Oxytetracycline ( Case Number 0655) in Support of the 2006 TREDs This 5 page 2006 document presents a brief background of the steps taken in the tolerance reassessment process to date and a series of questions to focus public comments, particularly on ways to reduce the likelihood of contributing to the development of antibiotic resistant bacteria through the continued use of streptomycin and/ or oxytetracycline.


[Federal Register Volume 78, Number 161 (Tuesday, August 20, 2013)]
[Notices]
[Pages 51203-51204]
[FR Doc No: 2013-20321]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4135-DR; Docket ID FEMA-2013-0001]

Iowa; Major Disaster and Related Determinations

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of the Presidential declaration of a major
disaster for the State of Iowa (FEMA-4135-DR), dated July 31, 2013, and
related determinations.

DATES: Effective Date: July 31, 2013.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter
dated July 31, 2013, the President issued a major disaster declaration
under the authority of the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ``Stafford
Act''), as follows:

    I have determined that the damage in certain areas of the State
of Iowa resulting from severe storms, tornadoes, and flooding during
the period June 21-28, 2013, is of sufficient severity and magnitude
to warrant a major disaster declaration under the Robert T. Stafford
Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq.
(the ``Stafford Act''). Therefore, I declare that such a major
disaster exists in the State of Iowa.
    In order to provide Federal assistance, you are hereby
authorized to allocate from funds available for these purposes such
amounts as you find necessary for Federal disaster assistance and
administrative expenses.
    You are authorized to provide Public Assistance in the
designated areas and Hazard Mitigation throughout the State.
Consistent with the requirement that Federal assistance be
supplemental, any Federal funds provided under the Stafford Act for
Hazard Mitigation will be limited to 75 percent of the total
eligible costs. Federal funds provided under the Stafford Act for
Public Assistance also will be limited to 75 percent of the total
eligible costs, with the exception of projects that meet the
eligibility criteria for a higher Federal cost-sharing percentage
under the Public Assistance Alternative Procedures Pilot Program for
Debris Removal implemented pursuant to Section 428 of the Stafford
Act.
    Further, you are authorized to make changes to this declaration
for the approved assistance to the extent allowable under the
Stafford Act.

    The Federal Emergency Management Agency (FEMA) hereby gives notice
that pursuant to the authority vested in the Administrator, under
Executive Order 12148, as amended, Joe M. Girot, of FEMA is appointed
to act as the Federal Coordinating Officer for this major disaster.
    The following areas of the State of Iowa have been designated as
adversely affected by this major disaster:

Allamakee, Benton, Buchanan, Butler, Cedar, Clayton, Delaware,
Howard, Jones, and Winneshiek Counties for Public Assistance.
    All counties within the State of Iowa are eligible to apply for
assistance under the Hazard Mitigation Grant Program.

    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used

for reporting and drawing funds: 97.030, Community Disaster Loans;
97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster
Legal Services; 97.034, Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant; 97.048, Disaster Housing
Assistance to Individuals and Households In Presidentially Declared
Disaster Areas; 97.049, Presidentially Declared Disaster
Assistance--Disaster Housing Operations for Individuals and
Households; 97.050, Presidentially Declared Disaster Assistance to
Individuals and Households--Other Needs; 97.036, Disaster Grants--
Public Assistance (Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.

W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2013-20321 Filed 8-19-13; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register: May 15, 2008 (Volume 73, Number 95)]
[Notices]
[Page 28178-28180]
[DOCID:fr15my08-96]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-57805; File No. SR-NYSEArca-2008-46]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
of Proposed Rule Change Relating to the Listing and Trading of Shares
of the NETS ISEQ 20 Index Fund (Ireland)

May 8, 2008.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on May 8, 2008, NYSE Arca, Inc. (``NYSE Arca'' or ``Exchange''),
through its wholly owned subsidiary, NYSE Arca Equities, Inc. (``NYSE
Arca Equities''), filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been substantially prepared by the
Exchange. The Commission is publishing this notice to solicit comments
on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to list and trade the shares (``Shares'') of
the NETS ISEQ 20[supreg] Index Fund (Ireland) (``Fund'') issued by the
NETS Trust (``Trust''). The text of the proposed rule change is
available at the Exchange, the Commission's Public Reference Room, and
http://www.nyse.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
Sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to list and trade the Shares pursuant to NYSE
Arca

Equities Rule 5.2(j)(3), the Exchange's listing standards for
Investment Company Units (``ICUs'').\3\ The Fund is an ``index fund''
that seeks to provide investment results that correspond generally to
the price and yield performance, before fees and expenses, of publicly-
traded securities in the aggregate in the Irish market, as represented
by the ISEQ 20[supreg] (``Index''). The primary market for securities
in the Index is the Irish Stock Exchange.
---------------------------------------------------------------------------

    \3\ An ICU is a security that represents an interest in a
registered investment company that holds securities comprising, or
otherwise based on or representing an interest in, an index or
portfolio of securities (or holds securities in another registered
investment company that holds securities comprising, or otherwise
based on or representing an interest in, an index or portfolio of
securities). See NYSE Arca Equities Rule 5.2(j)(3).
---------------------------------------------------------------------------

    The Exchange submits this proposed rule change because the Index
for the Fund does not meet all of the ``generic'' listing requirements
of Commentary .01(a)(B) to NYSE Arca Equities Rule 5.2(j)(3) applicable
to the listing of ICUs based on international or global indexes. The
Index meets all such requirements except for those set forth in
Commentary .01(a)(B)(3).\4\ The Exchange represents that: (1) Except
for the requirement under Commentary .01(a)(B)(3) to NYSE Arca Equities
Rule 5.2(j)(3) relating to the five most heavily weighted component
stocks, the Shares of the Fund currently satisfy all of the generic
listing standards under NYSE Arca Equities Rule 5.2(j)(3); (2) the
continued listing standards under NYSE Arca Equities Rules 5.2(j)(3)
and 5.5(g)(2) applicable to ICUs will apply to the Shares; and (3) the
Trust is required to comply with Rule 10A-3 under the Act \5\ for the
initial and continued listing of the Shares. In addition, the Exchange
represents that the Shares will comply with all other requirements
applicable to ICUs including, but not limited to, requirements relating
to the dissemination of key information such as the Index value and
Intraday Indicative Value, rules governing the trading of equity
securities, trading hours, trading halts, surveillance, and Information
Bulletin to ETP Holders, as set forth in prior Commission orders
approving the generic listing rules applicable to the listing and
trading of ICUs.\6\
---------------------------------------------------------------------------

    \4\ The Exchange states that the Index satisfies the first
requirement under Commentary .01(a)(B)(3) to NYSE Arca Equities Rule
5.2(j)(3) that the most heavily weighted component stock shall not
exceed 25% of the weight of the index or portfolio. However, the
Index fails to meet the second requirement of Commentary
.01(a)(B)(3) to NYSE Arca Equities Rule 5.2(j)(3) that the five most
heavily weighted component stocks shall not exceed 60% of the weight
of the Index. The Exchange states that, as of April 18, 2008, the
five most heavily weighted component stocks represented 68.7% of the
Index weight.
    \5\ See 17 CFR 240.10A-3.
    \6\ See, e.g., Securities Exchange Act Release Nos. 55621 (April
12, 2007), 72 FR 19571 (April 18, 2007) (SR-NYSEArca-2006-86)
(approving generic listing standards for ICUs based on international
or global indexes); 44551 (July 12, 2001), 66 FR 37716 (July 19,
2001) (SR-PCX-2001-14) (approving generic listing standards for ICUs
and Portfolio Depositary Receipts); and 41983 (October 6, 1999), 64
FR 56008 (October 15, 1999) (SR-PCX-98-29) (approving rules for the
listing and trading of ICUs).
---------------------------------------------------------------------------

    The Exchange states that detailed descriptions of the Fund, the
Index, procedures for creating and redeeming Shares, transaction fees
and expenses, dividends, distributions, taxes, and reports to be
distributed to beneficial owners of the Shares can be found in the
Trust's Registration Statement \7\ or on the Web site for the Fund
(http://www.netsetfs.com), as applicable.
---------------------------------------------------------------------------

    \7\ See Registration Statement on Form N-1A dated February 13,
2008 (File Nos. 333-147077 and 811-22140).
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act,\8\ in general, and furthers the
objectives of Section 6(b)(5) of the Act,\9\ in particular, in that it
is designed to prevent fraudulent and manipulative acts and practices,
to promote just and equitable principles of trade, to foster
cooperation and coordination with persons engaged in facilitating
transactions in securities, and to remove impediments to and perfect
the mechanism of a free and open market and a national market system.
The Exchange believes that the proposed rule change will facilitate the
listing and trading of additional types of exchange-traded products
that will enhance competition among market participants, to the benefit
of investors and the marketplace.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b).
    \9\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    The Exchange states that written comments on the proposed rule
change were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 35 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the Exchange consents, the Commission will:
    A. By order approve such proposed rule change; or
    B. Institute proceedings to determine whether the proposed rule
change should be disapproved.

The Exchange has requested accelerated approval of this proposed rule
change prior to the 30th day after the date of publication of the
notice of the filing thereof. The Commission is considering granting
accelerated approval of the proposed rule change at the end of a 15-day
comment period.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NYSEArca-2008-46 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2008-46. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/
rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than

those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of the filing also will be available for
inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-NYSEArca-2008-46 and should
be submitted on or before May 30, 2008.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\10\
---------------------------------------------------------------------------

    \10\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
 [FR Doc. E8-10803 Filed 5-14-08; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register Volume 83, Number 75 (Wednesday, April 18, 2018)]
[Notices]
[Pages 17220-17221]
[FR Doc No: 2018-08060]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[Docket No. NHTSA-2013-0021, Notice 3]

Correction to Decision That Nonconforming Model Year 2000 East
Lancashire Coachbuilders Limited Double Decker Tri-Axle Buses (With
Volvo B7L Chassis) Are Eligible for Importation

AGENCY: National Highway Traffic Safety Administration (NHTSA),
Department of Transportation (DOT).

ACTION: Correction to previous import eligibility decision.

-----------------------------------------------------------------------

SUMMARY: NHTSA is correcting an error made in its decision that certain
model year (MY) 2000 East Lancashire Coachbuilders Limited Double
Decker Tri-Axle buses (with Volvo B7L Chassis) that were not originally
manufactured to comply with all applicable Federal Motor Vehicle Safety
Standards (FMVSS) are eligible for importation into the United States
because they have safety features that comply with, or are capable of
being altered to comply with, all applicable FMVSS. The correction is
being made to properly identify the subject vehicles as MY 2001 models.

DATES: The original eligibility decision became effective on July 30,
2015. The correction is effective as of April 8, 2018, and applies to
any vehicle that may have been previously imported under the original
eligibility decision.

ADDRESSES: For further information contact George Stevens, Office of
Vehicle Safety Compliance, NHTSA<PHONE_NUMBER>).

SUPPLEMENTARY INFORMATION:

Background

    Under 49 U.S.C. 30141(a)(1)(B), a motor vehicle that was not
originally manufactured to conform to all applicable FMVSS shall be
refused admission into the United States unless NHTSA has decided its
safety features comply with, or are capable of being altered to comply
with, all applicable FMVSS based on destructive test data or such other
evidence that NHTSA decides to be adequate.
    Petitions for eligibility decisions may be submitted by either
manufacturers or importers who have registered with NHTSA pursuant to
49 CFR part 592. As specified in 49 CFR 593.7, NHTSA publishes notice
in the Federal Register of each petition that it receives, and affords
interested persons an opportunity to comment on the petition. At the
close of the comment period, NHTSA decides, on the basis of the
petition and any comments that it has received, whether the vehicle is
eligible for importation. The agency then publishes this decision in
the Federal Register.
    US Specs, of Havre de Grace, Maryland (``US Specs'') (Registered
Importer No. RI-03-321), petitioned NHTSA to decide whether MY 2000
East Lancashire Coachbuilders Limited Double Decker Tri-Axle buses
(with Volvo B7L Chassis) are eligible for importation into the United
States. NHTSA published a notice of the petition on January 26, 2015
(80 FR 4033) to afford an opportunity for public comment. No comments
were received. The reader is referred to that notice for a thorough
description of the petition.
    A decision granting the referenced petition was published on August
25, 2015 (80 FR 46645). Under the decision, certain MY 2000 East
Lancashire Coachbuilders Limited Double Decker Tri-Axle buses (with
Volvo B7L Chassis) were determined eligible for importation into the
United States.
    Import eligibility decisions are made on a make, model, and model
year basis, typically in response to petitions submitted by a RI. As
specified in 49 CFR 593.6(b)(1), the petitioning RI must, among other
things, identify the model year and model of the vehicle for which
import eligibility is sought.
    In its petition, US Specs identified the subject vehicle as a MY
2000 East Lancashire Coachbuilders Limited Double Decker Tri-Axle
buses, built on a Volvo B7L Chassis. At time of submission, there was
no reason for NHTSA to question this identification of the vehicle.
    It has since come to the agency's attention that manufacturing
operations on the subject vehicle were completed in calendar year 2001,
the same year in which the bus entered service. Absent a model year
designation from the manufacturer or the vehicle's country of origin,
the year in which manufacturing operations are completed on the vehicle
serves as the vehicle's model year, as that term is defined in 49 CFR
593.4.

Correction

    Accordingly, on the basis of the foregoing, NHTSA hereby corrects
the decision granting import eligibility to MY 2000 East Lancashire
Coachbuilders Limited Double Decker Tri-Axle buses (mounted on a Volvo
B7L Chassis) to identify the subject vehicles as the MY 2001 version.
    Conditions for importation of vehicles eligible under this
corrected decision remain as outlined in the original decision. The
importer of a vehicle

admissible under any final decision must indicate on the form HS-7
accompanying entry the appropriate vehicle eligibility number
indicating that the vehicle is eligible for entry. VCP-59, the vehicle
eligibility number assigned to vehicles admissible under the original
decision, remains as the eligibility number for vehicles admissible
under the decision as corrected in this notice.

    Authority:  49 U.S.C. 30118, 30120: delegations of authority at
49 CFR 1.95 and 501.8.

Claudia W. Covell,
Acting Director, Office of Vehicle Safety Compliance.
[FR Doc. 2018-08060 Filed 4-17-18; 8:45 am]
 BILLING CODE 4910-59-P


[Federal Register: August 31, 2007 (Volume 72, Number 169)]
[Notice]
[Page 50353]
[DOCID:fr31au07-84]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP06-90-003]

WTG Hugoton, LP; Notice of Compliance Filing

August 22, 2007.
    Take notice that on August 14, 2007, WTG Hugoton, LP (WTG) tendered
for filing as part of its FERC Gas Tariff, Original Volume No. 1, First
Revised Sheet No. 238; First Revised Sheet No. 255 and Original Sheet
No. 255A, with an effective date of August 1, 2007.
    Any person desiring to protest this filing must file in accordance
with Rule 211 of the Commission's Rules of Practice and Procedure (18
CFR 385.211). Protests to this filing will be considered by the
Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Such protests
must be filed on or before the date as indicated below. Anyone filing a
protest must serve a copy of that document on all the parties to the
proceeding.
    The Commission encourages electronic submission of protests in lieu
of paper using the ``eFiling'' link at http://www.ferc.gov. Persons
unable to file electronically should submit an original and 14 copies
of the protest to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Protest Date: 5 p.m. Eastern Time September 4, 2007.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-17238 Filed 8-30-07; 8:45 am]

BILLING CODE 6717-01-P